tiprankstipranks
Advertisement
Advertisement
Novocure announces results from Phase 2 PANOVA-4 trial met primary endpoint
PremiumThe FlyNovocure announces results from Phase 2 PANOVA-4 trial met primary endpoint
29d ago
Novocure gets reimbursement approval in Japan for Optune Lua
Premium
The Fly
Novocure gets reimbursement approval in Japan for Optune Lua
2M ago
Novocure gets reimbursement approval in Japan for Optune Lua
Premium
The Fly
Novocure gets reimbursement approval in Japan for Optune Lua
2M ago
Novocure jumps 11% after CMS reinstates Medicare billing privileges
PremiumThe FlyNovocure jumps 11% after CMS reinstates Medicare billing privileges
2M ago
NovoCure Has Medicare Billing Privileges Reinstated by CMS
Premium
Company Announcements
NovoCure Has Medicare Billing Privileges Reinstated by CMS
2M ago
NVCR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
NVCR Upcoming Earnings Report: What to Expect?
2M ago
Novocure price target raised to $47 from $39 at H.C. Wainwright
PremiumThe FlyNovocure price target raised to $47 from $39 at H.C. Wainwright
2M ago
Novocure’s Optune Pax approved by FDA to treat pancreatic cancer
Premium
The Fly
Novocure’s Optune Pax approved by FDA to treat pancreatic cancer
2M ago
Novocure Wins FDA Approval for Optune Pax in Pancreatic Cancer
Premium
Company Announcements
Novocure Wins FDA Approval for Optune Pax in Pancreatic Cancer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100